CoChat

Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Purpose Phentermine/topiramate combination therapy resulted in significant weight loss and improvements in cardiometabolic risk factors in patients with obesity/overweight in two published 56-week randomized, placebo-controlled trials (EQUIP and CONQUER). The purpose of the current study was to examine whether phentermine/topiramate is also associated with greater improvements in health-related quality of life (HRQOL) and whether HRQOL improvements are solely attributable to weight reduction.Methods Patients in EQUIP (n = 751) had a body mass index (BMI) ≥ 35 with no obesity-related comorbidity. Patients in CONQUER (n = 1623) had a BMI ≥ 27 and ≤ 45 and at least two obesity-related comorbid conditions. HRQOL was assessed with Impact of Weight on Quality of Life-Lite (IWQOL-Lite) and Medical Outcomes Study Short Form (SF-36) (CONQUER only).Results Significant improvements in both obesity-specific and physical HRQOL were observed at 56 weeks in both trials (p < .0001). In EQUIP, BMI reduction fully mediated improvements in IWQOL-Lite total score (p < .0001). In CONQUER, both BMI reduction (all p values < .0001) and change in depressive symptoms (all p values < .025) were significant mediators of improved IWQOL-Lite total score and SF-36 Physical Component Summary score. Gender, psychiatric history, and baseline triglycerides moderated these relationships.Conclusions Both trials demonstrated that treatment with phentermine/topiramate improved HRQOL compared with placebo. Although reduction in BMI accounted for the majority of improvements in obesity-specific and physical HRQOL, decrease in depressive symptoms was also a significant mediator. Results highlight the predominance of weight reduction as a key factor in improving HRQOL in obesity.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11136-015-1153-x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 42 · Cited by 24

Metadata

Authors
Kolotkin, R. L., Gadde, K. M., Peterson, C. A., & Crosby, R. D.
Affiliations
  • Duke University (US)
  • Pennington Biomedical Research Center (US)
  • Vivus (United States) (US)
  • University of North Dakota (US)
Corresponding author
Kolotkin, Ronette L.
Venue
Quality of Life Research
Published
2015-10-07
Volume
25
Issue
5
Pages
1237-1244
ISSN
  • 0962-9343 (ISSN-L)
  • 1573-2649
OpenAlex
W1826001489
Cited by
24
References
42
Citations by year
2026: 2 · 2025: 3 · 2024: 4 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 6 · 2016: 1
FWCI
2.16
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Quality of Life Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Vivus (US)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
phentermine/topiramate, obesity, health-related quality of life, weight loss, mediation analysis, depressive symptoms, IWQOL-Lite, SF-36, obesity-related comorbidities, body mass index
MeSH terms
Topiramate, Adult, Body Weight, Depression, Female, Fructose, Health Status, Humans, Male, Middle Aged, Obesity, Phentermine, Quality of Life, Surveys and Questionnaires, Weight Loss, Body Mass Index, Randomized Controlled Trials as Topic, Outcome Assessment, Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement? https://app.cochat.ai/papers/10.1007/s11136-015-1153-x
The paper
Kolotkin, R. L., Gadde, K. M., Peterson, C. A., & Crosby, R. D. (2016). Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement? Quality of Life Research. https://doi.org/10.1007/s11136-015-1153-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.